EDGAR Filing Documents for 0001683168-22-003970

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001683168-22-003970

Filing Date

2022-05-24

Accepted

2022-05-23 20:21:52

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-1 AMENDMENT 1	coeptis_s1a1-inprogress.htm iXBRL	S-1/A	1510396
2	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	coeptis_ex2301.htm	EX-23.1	2750
3	CALCULATION OF FILING FEE TABLES	coeptis_ex107.htm	EX-FILING FEES	27542
	Complete submission text file	0001683168-22-003970.txt		5288959

Data Files

Seq	Description	Document	Type	Size
4	XBRL SCHEMA FILE	coep-20220331.xsd	EX-101.SCH	32989
5	XBRL CALCULATION FILE	coep-20220331_cal.xml	EX-101.CAL	75830
6	XBRL DEFINITION FILE	coep-20220331_def.xml	EX-101.DEF	144957
7	XBRL LABEL FILE	coep-20220331_lab.xml	EX-101.LAB	260668
8	XBRL PRESENTATION FILE	coep-20220331_pre.xml	EX-101.PRE	257319
46	EXTRACTED XBRL INSTANCE DOCUMENT	coeptis_s1a1-inprogress_htm.xml	XML	523512

Mailing Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090

Business Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090 724-934-6467

Coeptis Therapeutics Inc. (Filer) CIK: 0001819663 (see all company filings)